Table 2.
ICU management and outcome
| Variables | Patients |
|---|---|
| Neurocritical care, n (%) | |
| Acyclovir | 55 (100%) |
| High dose of steroids | 4 (7%) |
| Anticonvulsant therapy | 12 (22%) |
| Life-sustaining therapies | |
| Invasive mechanical ventilation (IMV), n (%) | 46 (84%) |
| Duration of IMV, days, median [IQR] | 13 [3–0] |
| Vasopressors, n (%) | 22 (40%) |
| Renal replacement therapy, n (%) | 15 (27%) |
| Outcome | |
| ICU mortality, n (%) | 14 (25%) |
| ICU length of stay, days, median [IQR] | 15 [6–38] |
| Hospital length of stay, days, median [IQR] | 35 [17–55] |
| One-year mortality | 18 (33%) |
AKI, acute kidney injury; ICU, intensive care unit; IQR, interquartile; VZV, varicella-zoster virus